Press Releases July 23, 2026 07:00 AM

Aqua Metals to Announce Second Quarter 2026 Financial Results and Host Investor Conference Call on July 30, 2026

Aqua Metals to report Q2 2026 financial results and update on commercialization of critical minerals recovery technology.

By Caleb Monroe
Share
Twitter Reddit Facebook LinkedIn
AQMS

Aqua Metals, a U.S.-based company commercializing lower-cost critical minerals recovery and refining technologies, announced it will release its second quarter 2026 financial results on July 30, 2026, accompanied by a business update and investor conference call. The company highlighted its AquaRefining™ process and plans to expand its Headwaters ARC campus to process various battery materials and critical minerals, supporting U.S. manufacturing and supply chain resilience.

Aqua Metals to Announce Second Quarter 2026 Financial Results and Host Investor Conference Call on July 30, 2026
AQMS
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Aqua Metals will report Q2 2026 financial results and provide a business update on July 30, 2026.
  • The company is advancing its AquaRefining™ technology to process lithium-ion battery materials and other critical minerals domestically.
  • Their Headwaters ARC campus aims to recover copper, aluminum, black mass, lithium carbonate, and iron phosphate to support critical mineral supply chains in the U.S.

RENO, Nev., July 23, 2026 (GLOBE NEWSWIRE) -- Aqua Metals, Inc. (NASDAQ: AQMS), a U.S. critical minerals processing company commercializing lower-cost recovery and refining technologies, today announced it will report financial results for the second quarter ended June 30, 2026, and provide a business update on Thursday, July 30, 2026. Management will host a conference call that day at 4:30 p.m. ET.

The live conference call and replay can be accessed from the investor relations section of the Company’s website at https://ir.aquametals.com/.

About Aqua Metals

Aqua Metals (NASDAQ: AQMS) is commercializing a lower-cost approach to recovering and processing critical minerals in the United States. Its patented AquaRefining™ process is designed to eliminate costly one-time-use chemicals, reduce waste streams and associated disposal costs, and provide a safer working environment than conventional metals processing methods.

The Company’s staged commercialization strategy combines established mechanical processing with AquaRefining™ technology. Through its planned Headwaters ARC campus, Aqua Metals intends to recover copper, aluminum and black mass from segregated LFP battery materials using commercially proven equipment, establishing a pathway to revenue through processing before adding a simplified AquaRefining™ process to recover and valorize lithium carbonate and iron phosphate. The planned Headwaters ARC campus is designed to expand over time to process NMC battery materials and other critical mineral feedstocks, leveraging a common processing platform to serve multiple domestic supply chains.

Aqua Metals is advancing applications across battery materials, rare earth elements and other critical mineral resources. Its strategy is designed to support advanced U.S. manufacturing, create high-quality domestic jobs, strengthen resilient domestic supply chains, and enable lower-cost production of critical minerals essential to energy storage, electrification, defense and other strategic industries. For more information, visit www.aquametals.com

Contacts

For Media and Investor Inquiries: [email protected]


Risks

  • Commercial success depends on scaling the AquaRefining™ technology and the Headwaters ARC campus as planned.
  • Market demand and pricing for recovered critical minerals and battery materials may fluctuate, impacting revenues.
  • Potential regulatory, technological, and operational challenges in expanding processing capabilities and domestic critical minerals supply chain integration.

More from Press Releases

Willis appoints Trevor Madden as Head of Captive and Insurance Management Solutions, Asia Pacific Sep 6, 2026 Zhihu Inc. Announces Proposed Subscription in AI-Focused Investment Fund Sep 6, 2026 Roivant to Present Topline Results from the Phase 2 PHocus Study of Mosliciguat in Patients with Pulmonary Hypertension Associated with Interstitial Lung Disease (PH-ILD) at the ERS Congress 2026 on Tuesday, September 8, 2026, and Host Investor Call Sep 6, 2026 Verizon Waives Charges for Hurricane Lowell, Prepares Network in Hawai'i Sep 5, 2026 Royalty Pharma announces update on Novartis’ Phase 3 topline results for pelacarsen Sep 4, 2026